menu search

Mineralys therapeutics announces upcoming poster presentations at two scientific conferences in november 2023

Late-breaking poster presentation at ASN’s Kidney Week 2023 – – –Poster presentation at AHA’s Scientific Sessions 2023 RADNOR, Pa., Oct. 13,...

October 13, 2023, 8:10 pm

Revolution medicines presents encouraging clinical data for rmc-6236 and rmc-6291 at 2023 triple meeting

Clinical dose escalation data for RMC-6236, a RASMULTI(ON) Inhibitor, show oral bioavailability, well-tolerated safety profile and preliminary evidenc...

October 13, 2023, 3:50 pm

Why shares of revolution medicines were popping on friday

Revolution medicines is a clinical-stage biotech. The company has nearly a million in cash to develop i...

October 13, 2023, 2:54 pm

Cidara therapeutics and mundipharma receive positive chmp opinion for rezafungin for the treatment of invasive candidiasis in adults(1)

The opinion was based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and e...

October 13, 2023, 2:34 pm

Intellia therapeutics receives priority medicines (prime) designation from the european medicines agency for ntla-2002, an investigational in vivo crispr genome editing treatment for hereditary angioe

CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focuse...

October 13, 2023, 12:38 pm

Intellia therapeutics receives priority medicines (prime) designation from the european medicines agency for ntla-2002, an investigational in vivo crispr genome editing treatment for hereditary angioe

CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focuse...

October 13, 2023, 12:38 pm

: amylyx pharmaceuticals shares fall after als treatment is rejected by european regulator

Amylyx Pharmaceuticals Inc. AMLX shares fell 7.5% premarket on Friday after the company said the European medi...

October 13, 2023, 12:31 pm

Amylyx pharmaceuticals's als dug rejected again by eu regulators

Amylyx Pharmaceuticals shares fell Friday after its ALS (amyotrophic lateral sclerosis) drug was denied marketing authorization by European Union regu...

October 13, 2023, 11:38 am

Amylyx pharmaceuticals shares fall after als treatment is rejected by european regulator

Amylyx Pharmaceuticals Inc. AMLX, -4.60% shares fell 7.5% premarket on Friday after the company said the European ...

October 13, 2023, 8:31 am

Eu regulator declines to recommend amylyx' als drug

Amylyx Pharmaceuticals said on Friday the European Union medicines regulator for the second time declin...

October 13, 2023, 8:28 am

Eu regulator backs pfizer's blood cancer therapy

The European Union medicines regulator on Friday recommended a conditional marketing authorization for ...

October 13, 2023, 8:05 am

Ardelyx to present data updates for xphozah (tenapanor) for hyperphosphatemia at kidney week 2023 november 1-5 in philadelphia, pa

WALTHAM, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develo...

October 13, 2023, 8:00 am

Nanoviricides, inc. to present at the partnership opportunities in drug delivery conference in boston on october 16, 2023 at 6:07pm et

SHELTON, CT / ACCESSWIRE / October 12, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), announces that the Company's President, Dr. An...

October 12, 2023, 6:45 am

Annexon announces clinical and regulatory progress for anx005 pivotal program in guillain-barré syndrome (gbs)

ANX005 Granted Orphan Drug Designation by the European medicines Agency for the Treatment of GBS Target...

October 10, 2023, 10:30 am

Should you sell this stock after another regulatory headwind?

Eli Lilly set out to launch four new products this year, but it is unlikely to do so. The company's regulatory roadblocks aren't deal-breakers for its...

October 6, 2023, 6:09 am

Infinity pharmaceuticals, inc. investors: lead plaintiff deadline is approaching in the class action against infinity pharmaceuticals, inc.; contact robbins llp today

SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities ...

October 5, 2023, 7:18 pm

Investing in moderna: a speculative buy for long-term gains

Moderna is a biotech company with high potential upside, despite the decline in demand for its COVID-19 vaccine. The company's mRNA platform approach ...

October 5, 2023, 3:21 pm

Wegovy class has higher gi side effect risk than older weight loss drug in study

medicines in the same class as Novo Nordisk's popular weight-loss therapy Wegovy may carry an increased...

October 5, 2023, 2:31 pm

Revolution medicines to present new clinical data at major oncology conferences and host investor webcast

Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor) Company to Host Investor Webcast Following ESM...

October 4, 2023, 8:05 pm

Immuneering to present preclinical data on imm-1-104 and imm-6-415 at aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing ...

October 4, 2023, 4:05 pm


Search within

Pages Search Results: